A Phase 1/1b Multicenter Study to Evaluate the Humanized Anti-CD 73 Antibody, CP-I006, As A Single Agent, In Combination With CPI-444, And In Combination With Pembrolizumab In Adult Subjects With Advanced Cancers

Project: Other

Project Description

NMA HREC Reference Number: HREC/18/MonH/453
NMA SSA Reference Number: SSA/41248/MonH-2018-67279(v1)
Monash Health Ref: RES-18-0000-373A
StatusActive
Effective start/end date12/02/19 → 11/02/24
View all
View less